Takeda Brazil

Takeda Brazil is part of the Takeda family of companies. With the establishment of Takeda Brazil, Takeda expands its commercial capabilities into a growing Latin American market in order to bring important medicines to the people of Brazil.

Takeda focuses on a variety of therapeutic areas including diabetes, cardiovascular diseases, rheumatology, oncology and urological diseases, central nervous system disorders and gastrointestinal diseases.

Based in Osaka, Japan, Takeda Pharmaceutical Company Limited was founded more than 227 years ago. Takeda operates in numerous countries including Japan, United States, China, Singapore, Taiwan, Thailand, Philippines, Canada, Austria, France, Ireland, Switzerland, Germany, England, Italy and Mexico. In addition to our research and development sites in the United States, Takeda has global research centers in Japan, the United Kingdom and Singapore.

Improving the lives of patients is at the center of everything we do. Our mission is to strive toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Takeda’s commitment to patients, employees, shareholders and the community is an integral part of our goal to continue to build on our success as a global leader in the pharmaceutical industry.